Jul 3 |
Bain, Cinven Weighing Joint Bid for $20 Billion Sanofi Unit
|
Jul 3 |
Europe Approves Sanofi/Regeneron's Dupixent for 'Smoker's Lungs' A Month After US FDA Asks For Data
|
Jul 3 |
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
|
Jul 3 |
Sanofi, Regeneron win EU label expansion for Dupixent in COPD
|
Jul 3 |
EMA approves Sanofi’s Dupixent for COPD treatment in adults
|
Jul 3 |
Update: Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
|
Jul 3 |
Press Release: Dupixent approved in the EU as the first-ever targeted therapy for patients with COPD
|
Jul 2 |
Market Chatter: Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits
|
Jul 1 |
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
|
Jul 1 |
Bird Flu Shot Hopes Dim as Tracing Woes Undercut Covid Lessons
|